Results 131 to 140 of about 58,145 (215)

Effect of Treatment of Hypokinetic Dysarthria in Parkinson's Disease with Speech and Language Therapy: A Meta-Analysis. [PDF]

Iran J Public Health
Zhang L.
europepmc   +1 more source

Cost-effectiveness of speech and language therapy plus scalp acupuncture versus speech and language therapy alone for community-based patients with Broca's aphasia after stroke: a post hoc analysis of data from a randomised controlled trial. [PDF]

BMJ Open, 2021
Liu Z, Huang J, Xu Y, Wu J, Tao J, Chen L.   +5 more
europepmc   +1 more source

Stem Cell Transplantation in Friedreich Ataxia: Cure for Leukemia but No Effect on Neurological Progression

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Friedreich Ataxia (FRDA) is a neurodegenerative disorder of children and young adults associated with cardiomyopathy and other systemic complications. We report a 10‐year‐old girl who presented simultaneously with Acute Myelogenous Leukemia and FRDA who was successfully treated for her leukemia with allogeneic hematopoietic stem cell ...
Alexandra Gitman, Niyati Bhandari, Maria Castellaro, Kim Schadt, María Cancio, David R. Lynch   +5 more
wiley   +1 more source

"Not That I've Become Exceptional, But I'm Able to Make Myself Understood Better": Impact of Speech and Language Therapy on Everyday Communication in People with Primary Progressive Aphasia and Their Carers. [PDF]

Neurol Ther
Palmirotta C, Santi GC, Aresta S, Tomasoni R, Benzini A, Leccese G, Santacesaria P, Tagliente S, Cosseddu M, Biddau F, Introna A, Capozzo R, Tagliente S, Padovani A, Fiore P, Battista P.   +15 more
europepmc   +1 more source

A descriptive case report of telesupervision and online case-based learning for speech and language therapy students in Vietnam during the COVID-19 pandemic. [PDF]

S Afr J Commun Disord, 2022
McAllister LL, Atherton M, Winkworth A, Wells S, Le DK, Sandweg K, Nguyen TTT, Henderson-Faranda N, Broadmore S.   +8 more
europepmc   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Influence of Speech and Language Therapy on Quality of Life in People With Primary Progressive Aphasia: A Scoping Review. [PDF]

Int J Lang Commun Disord
Gauch M, Spelter B, Geschke K, Köb AL, Tüscher O, Heinrich I, Corsten S.   +6 more
europepmc   +1 more source

A 57‐Year‐Old Male With Behavioral Variant Frontotemporal Dementia and MATR3 and NOS3 Mutations

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This report presents a case of behavioral variant frontotemporal dementia caused by mutations in the MATR3 and NOS3 genes, aiming to analyze its clinical manifestations and genetic characteristics. For a case presenting with personality changes and gait abnormalities as the initial symptoms, this study conducted a comprehensive analysis of its
Feifei Lin, Saie Huang
wiley   +1 more source

Right C7 neurotomy at the intervertebral foramen plus intensive speech and language therapy versus intensive speech and language therapy alone for chronic post-stroke aphasia: multicentre, randomised controlled trial. [PDF]

BMJ
Feng J, Hu R, Lyu M, Ma X, Li T, Meng Y, Qi W, Li H, Zhang Y, Ding S, Wang Z, Chen X, Zheng J, Fan Y, Ding L, Wang L, Wei Z, Zhu X, Guo M, Yang K, Chang W, Yang J, Xu M, Fang W, Liu Y, Qiu Y, Yin H, Jia J, Shen Y, Wang Y, Gu Y, Xu W.   +31 more
europepmc   +1 more source

Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Stroke clinical trials are essential for advancing stroke care but can face challenges with recruitment, retention, clinical relevance, and translation into real‐world practice. We propose that integrating community engagement and implementation science approaches into stroke trials can help address these needs.
Lesli E. Skolarus, Devin L. Brown, Bernadette Boden‐Albala   +2 more
wiley   +1 more source